ENVISION SUMMIT 2022
THE NEXT HORIZON IN PRECISION ONCOLOGY: NEW DRUGS AND DIAGNOSTICS
COORDINATION
Dr. Aleix Prat, Hospital Clínic of Barcelona and President of SOLTI
Dr. Tomás Pascual, SOLTI’s Medical Director
PROGRAM
10:00 – Welcome
Coordinators
10:10 – Minimal residual disease
Dr. Nick Turner, The Institute of Cancer Research, London
10:40 – Discussion
Dr. Nick Turner, coordinators
10:55 – Endocrine therapy in early development
Dr. Susan Galbraith, EVP Oncology R&D, AstraZeneca and AACR Board of Directors member
11:25 – Discussion
Dr. Susan Galbraith, coordinators
11:40 – Break
12:10 – ADCs across cancer types
Dr. Barbara Pistilli, Institut Gustave Roussy, Paris
12:40 – Discussion
Dr. Barbara Pistilli, coordinators
12:55 – Immunotherapy
Dr. Sonia Guedan, Hospital Clínic of Barcelona
13:25 – Discussion
Dr. Sonia Guedan, coordinators
13:25 – Conclusions and closure
13:45 – Lunch
